Patents Assigned to OccuRx Pty Ltd
  • Methods of treating eye diseases associated with inflammation and vascular proliferation
    Patent number: 11583535
    Abstract: Methods for treating eye diseases associated with inflammation and/or vascular proliferation in subjects are disclosed. The methods include administering therapeutically effective amounts of a tranilast compound, in particular (E)-2-[[3-(3-Methoxy-4-propargyloxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or (E)-2-[[3,4-Bis(difluoromethoxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or pharmaceutically acceptable salts or solvates thereof.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: February 21, 2023
    Assignee: OCCURX PTY LTD
    Inventors: Darren James Kelly, David Stapleton
  • Methods of treating eye diseases associated with inflammation and vascular proliferation
    Patent number: 10786510
    Abstract: Methods for treating eye diseases associated with inflammation and/or vascular proliferation in subjects are disclosed. The methods include administering therapeutically effective amounts of a tranilast compound, in particular (E)-2-[[3-(3-Methoxy-4-propargyloxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or (E)-2-[[3,4-Bis(difluoromethoxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or pharmaceutically acceptable salts or solvates thereof.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: September 29, 2020
    Assignee: OccuRX Pty Ltd
    Inventors: Darren James Kelly, David Stapleton
  • Methods of treating eye diseases associated with inflammation and vascular proliferation
    Patent number: 10695353
    Abstract: Methods for treating eye diseases associated with inflammation and/or vascular proliferation in subjects are disclosed. The methods include administering therapeutically effective amounts of a tranilast compound, in particular (E)-2-[[3-(3-Methoxy-4-propargyloxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or (E)-2-[[3,4-Bis(difluoromethoxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or pharmaceutically acceptable salts or solvates thereof.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: June 30, 2020
    Assignee: Occurx Pty Ltd
    Inventors: Darren James Kelly, David Stapleton
  • Methods of treating eye diseases associated with inflammation and vascular proliferation
    Patent number: 9839640
    Abstract: Methods for treating eye diseases associated with inflammation and/or vascular proliferation in subjects are disclosed. The methods include administering therapeutically effective amounts of a tranilast compound, in particular (E)-2-[[3-(3-Methoxy-4-propargyloxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or (E)-2-[[3,4-Bis(difluoromethoxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or pharmaceutically acceptable salts or solvates thereof.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: December 12, 2017
    Assignee: OccuRx Pty Ltd
    Inventors: Darren James Kelly, David Stapleton